EUVIMEDEUVIMED entdecken
Open Access

A Peptide Inhibitor of Lymphocyte Activation Gene-3 Interaction with Fibrinogen-like Protein 1 Synergizes with Programmed Death-Ligand 1 Blockade to Restore T Cell Activity and Inhibit Tumor Growth

Seok-Min Lee, Smriti Gurung, Min-Sung Park, Sri Murugan Poongkavithai Vadevoo, Gowri Rangaswamy Gunassekaran, Min-Jong Kim, Sang-Hyun Kim, Ha-Jeong Kim, Eun Jung Park, Sangmin Lee, Wonpil Im, Soyoun Kim und 1 weitere

Biomaterials Research · 01.01.2026 · 30

DOI: 10.34133/bmr.0364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 14.05.2026. Verfasst von Seok-Min Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science and ICT, South Korea.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immune checkpoint lymphocyte activation gene-3 (LAG-3) interacts with major histocompatibility complex class II and fibrinogen-like protein 1 (FGL-1) to suppress T cell activity, contributing to resistance against immunotherapies such as programmed death-ligand 1 (PD-L1) blockade. This study aimed to identify LAG-3-binding peptides capable of disrupting these immunosuppressive interactions. Using a phage-displayed peptide library, we identified 2 candidate peptides, LAG3pep-1 and LAG3pep-2, that preferentially bound to LAG-3-expressing cells and recombinant LAG-3 protein. A LAG-3 D1 domain-blocking antibody competitively inhibited the peptide binding to LAG-3-expressing cells, confirming target specificity. Among the 2 peptides, LAG3pep-2 demonstrated higher binding affinity and greater stability toward LAG-3. These findings were further supported by structural modeling and all-atom simulation of the LAG-3 and peptide complexes and in silico mutational analysis. Functionally, LAG3pep-2 restored interleukin-2 secretion in T cells suppressed by tumor-derived FGL-1 more effectively than LAG3pep-1. Furthermore, LAG3pep-2 synergized with a PD-L1-blocking antibody to rescue T cell cytotoxicity and cytokine production in tumor cell co-culture assays. In vivo, systemic administration of LAG3pep-2 in combination with PD-L1 blockade significantly suppressed syngeneic tumor growth, enhanced anti-tumor immunity, and exhibited no observable systemic toxicity, outperforming either monotherapy. Collectively, these findings identify LAG3pep-2 as a peptide inhibitor of LAG-3 interaction with FGL-1 and a promising combinatorial agent to potentiate PD-L1-targeted cancer immunotherapies.

Autor:innen und Institutionen

  • Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Division of Biomedical Sciences, Graduate School, Kyungpook National University, Daegu, Republic of Korea.
  • Cell & Matrix Research Institute, Kyungpook National University, Daegu, Republic of Korea.
  • Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Department of Physiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang-si, Republic of Korea.

ORCID-Profile: Byungheon Lee

Förderung

  • Ministry of Science and ICT, South Korea

Zitieren

APA

Lee, S. M., Gurung, S., Park, M. S., Vadevoo, S. M. P., Gunassekaran, G. R., Kim, M. J., Kim, S. H., Kim, H. J., Park, E. J., Lee, S., Im, W., Kim, S., & Lee, B. (2026). A Peptide Inhibitor of Lymphocyte Activation Gene-3 Interaction with Fibrinogen-like Protein 1 Synergizes with Programmed Death-Ligand 1 Blockade to Restore T Cell Activity and Inhibit Tumor Growth. Biomaterials Research, 30. https://doi.org/10.34133/bmr.0364

Vancouver

Lee SM, Gurung S, Park MS, Vadevoo SMP, Gunassekaran GR, Kim MJ, et al. A Peptide Inhibitor of Lymphocyte Activation Gene-3 Interaction with Fibrinogen-like Protein 1 Synergizes with Programmed Death-Ligand 1 Blockade to Restore T Cell Activity and Inhibit Tumor Growth. Biomaterials Research. 2026;30. doi:10.34133/bmr.0364

BibTeX
@article{Lee2026,
  author = {Lee, Seok-Min and Gurung, Smriti and Park, Min-Sung and Vadevoo, Sri Murugan Poongkavithai and Gunassekaran, Gowri Rangaswamy and Kim, Min-Jong and Kim, Sang-Hyun and Kim, Ha-Jeong and Park, Eun Jung and Lee, Sangmin and Im, Wonpil and Kim, Soyoun and Lee, Byungheon},
  title = {A Peptide Inhibitor of Lymphocyte Activation Gene-3 Interaction with Fibrinogen-like Protein 1 Synergizes with Programmed Death-Ligand 1 Blockade to Restore T Cell Activity and Inhibit Tumor Growth},
  journal = {Biomaterials Research},
  year = {2026},
  volume = {30},
  doi = {10.34133/bmr.0364}
}
Kostenlos starten →